Rare diseases
Investigational molecules
Locations
Heinrich-Collin-Strasse 30, Penzing, 1140 Vienna, Austria
Hanusch Krankenhaus Der Wiener Gebietskrankenkasse in Vienna, Austria specialises in clinical trials of conditions such as Acute myeloid leukaemia, Chronic lymphocytic leukaemia, Plasma cell myeloma, Chronic myeloid leukaemia, and other specialisations. This site conducts important research.
The 3rd Medical Department for Hematology and Oncology at Hanusch Krankenhaus Der Wiener Gebietskrankenkasse focuses on innovative treatments for treatment‑naive chronic lymphocytic leukemia. Ongoing research tests targeted agents such as ibrutinib and venetoclax, often combined with obinutuzumab, to improve patient outcomes.
With two active studies and a team of 21 investigators, the site in Vienna is contributing to the European landscape of neoplasm research, aiming to establish safer and more effective first‑line options for patients.
Clinical trials currently enrolling participants at this site.
A Phase 3 Study of Sapablursen Compared with Placebo in Adults with Polycythemia Vera
AustriaStudy of Pivekimab Sunirine Combined with Venetoclax and Azacitidine in Adults with Newly Diagnosed Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy
AustriaStudy of pelabresib (DAK539) plus ruxolitinib versus placebo plus ruxolitinib in adult patients with myelofibrosis who are JAK‑inhibitor‑naive
AustriaLong-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
AustriaStudy of blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia
AustriaA study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.
AustriaStudy of oral rilzabrutinib for adults with immune thrombocytopenia who did not respond to first-line treatment
AustriaStudy of rilzabrutinib tablets compared to placebo in adults with warm autoimmune hemolytic anemia
AustriaStudy of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia
AustriaStudy on Ivosidenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed IDH1-Mutated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy
AustriaStudy Comparing BMS-986393 CAR T Cell Therapy to Standard Treatments for Adults with Relapsed or Refractory Multiple Myeloma Resistant to Lenalidomide
AustriaStudy on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
AustriaMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
